The Role of the Human Virome in Heart, Lung, and Blood Health and Resilience (R61/R33)
| Jurisdiction: | Federal |
| Incentive Type: | Grant Program |
| Industries: | Health And Safety, Research |
| Eligible Sector: | Business |
| Category: | Financial Incentive |
| Time Period: | FY 2015 |
| Governing Body: | National Institutes of Health |
| What’s it worth?: | Not mentioned |
The Role of the Human Virome in Heart, Lung, and Blood Health and Resilience program was designed to support research identifying and evaluating the basic underlying molecular and physiological mechanisms by which the virome influence specific organs including the heart, lung, and blood. Prioritized research areas include:
- Blood virome and its effect on transfusion recipients
- Interactions between the virome and the microbiome
- Role of the virome in mucosal development
- Fetal orgins of adult disease-how the virome in utero affects later life
- Role the virome plays in affecting the long flora and immune system
- Role the virome in heart health and diseases
- Role of the virome in respiratory bacterial exacerbations
- Effects of the virome on endothelium, coagulation and thrombus formation
- Mechanisms by which interactions between HIV and the virome contribute to the heart, lungs and blood
- Role of the virome in heart, lungs, and blood health in context of medical and pharmacological interventions
Over $2 million in funds are available for allocation; awards typically do not exceed $170,000 per project over up to a five year period. Proposal are expected to cover the actual needs of the proposed project and may cover maximum of five years.
This program does not have any cost sharing requirements. Applications must be complete and received before the deadline.
